Biological and mechanical evaluation of cinnamaldehyde doped liquid crystal-polymer composite membranes
Source abstract
Abstract
In this study cinnamaldehyde (CA) doped polyurethane cholesteryl pelargonate cholesteric liquid crystal composite membranes were produced and their properties were examined for use in biological applications. The relationship between the blood coagulation and protein adsorption was studied and the results showed that increasing CA concentration allowed an improvement in biological properties of them. Additionally, the effect of CA on the hyrophobicity of these membranes was investigated by determining water holding capacity, contact angles. The mechanical strength of these membranes were determined and it was found that their strength increased and the ability to elongate decreased with an increasing CA dopant concentration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Electrospun Nanofibers in Biomedical Applications · Polymer composites and self-healing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Engineering Faculty, Manisa Celal Bayar University, Manisa, Türkiye
Mechanical Engineering Department, Engineering Faculty, Doğuş Univeristy, İstanbul, Türkiye
Funding
‘Scientific Research Project Office of Manisa Celal Bayar University’
References (23)
Show source-provided references
1. 10.1126/science.120377110.1126/science.1203771 ↗
2. 10.1016/j.seppur.2020.11701310.1016/j.seppur.2020.117013 ↗
3. 10.1016/j.memsci.2013.12.05610.1016/j.memsci.2013.12.056 ↗
4. 10.1016/j.progpolymsci.2014.06.00110.1016/j.progpolymsci.2014.06.001 ↗
5. 10.1016/j.progpolymsci.2021.10145010.1016/j.progpolymsci.2021.101450 ↗
6. 10.1016/j.jece.2021.10636810.1016/j.jece.2021.106368 ↗
7. 10.1016/j.seppur.2021.11852910.1016/j.seppur.2021.118529 ↗
8. 10.1016/j.jallcom.2021.15901410.1016/j.jallcom.2021.159014 ↗
9. 10.1080/026782903100009745710.1080/0267829031000097457 ↗
10. 10.1016/s0142-9612(00)00222-210.1016/s0142-9612(00)00222-2 ↗
11. 10.1016/j.ijpharm.2006.07.04310.1016/j.ijpharm.2006.07.043 ↗
12. 10.1049/iet-nbt:2007001510.1049/iet-nbt:20070015 ↗
13. 10.1016/j.ssi.2019.02.02110.1016/j.ssi.2019.02.021 ↗
14. 10.1016/s0142-9612(99)00080-010.1016/s0142-9612(99)00080-0 ↗
15. Ye, Y.; Zhu, Q. The Development of Polyurethane. Department of Chemical Engineering 2017, 1, 1–8.
16. Alves, P.; Gil, H.; Ferreira, P. Biomedical Polyurethane-Based Materials. Chapter 2012, 1, 1–25.
17. 10.1039/C6RA14525F10.1039/C6RA14525F ↗
18. Mohy Eldin, M. S.; Hashem, H. I.; Omer, A. M.; Tamer, T. M. Wound Dressing Membranes Based on Chitosan: Preparation, Characterization and Biomedical Evaluation. Int. J. Adv. Res. 2015, 3(8), 908–922.
19. 10.1016/j.ijbiomac.2019.07.19110.1016/j.ijbiomac.2019.07.191 ↗
20. 10.1016/j.jfoodeng.2017.05.02310.1016/j.jfoodeng.2017.05.023 ↗
21. 10.3382/japr.2010-0018110.3382/japr.2010-00181 ↗
22. 10.1113/eph880249610.1113/eph8802496 ↗
23. Weiss, H.M.; Fresneau, M.; Camenisch, G.P.; Kretz, O.; Gross, G. In Vitro Blood Distribution and Plasma Protein Binding of the İron Chelator Deferasirox (ICL670) and İts İron Complex FE-[ICL670]2 for Rat, Marmoset, Rabbit, Mouse, Dog, and Human. Drug. Metabol. Disposit. 2006, 34, 971–975.